Mutant VAPB: Culprit or Innocent Bystander of Amyotrophic Lateral Sclerosis?
- PMID: 37366377
- PMCID: PMC10243577
- DOI: 10.1177/25152564211022515
Mutant VAPB: Culprit or Innocent Bystander of Amyotrophic Lateral Sclerosis?
Abstract
Nearly twenty years ago a mutation in the VAPB gene, resulting in a proline to serine substitution (p.P56S), was identified as the cause of a rare, slowly progressing, familial form of the motor neuron degenerative disease Amyotrophic Lateral Sclerosis (ALS). Since then, progress in unravelling the mechanistic basis of this mutation has proceeded in parallel with research on the VAP proteins and on their role in establishing membrane contact sites between the ER and other organelles. Analysis of the literature on cellular and animal models reviewed here supports the conclusion that P56S-VAPB, which is aggregation-prone, non-functional and unstable, is expressed at levels that are insufficient to support toxic gain-of-function or dominant negative effects within motor neurons. Instead, insufficient levels of the product of the single wild-type allele appear to be required for pathological effects, and may be the main driver of the disease. In light of the multiple interactions of the VAP proteins, we address the consequences of specific VAPB depletion and highlight various affected processes that could contribute to motor neuron degeneration. In the future, distinction of specific roles of each of the two VAP paralogues should help to further elucidate the basis of p.P56S familial ALS, as well as of other more common forms of the disease.
Keywords: endoplasmic reticulum (ER); intracellular inclusions; membrane contact sites; motor neuron; neurodegeneration; phosphoinositide.
© The Author(s) 2021.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
References
-
- Al-Chalabi A, van den Berg LH, Veldink J. (2017). Gene discovery in amyotrophic lateral sclerosis: implications for clinical management. Nat Rev Neurol 13, 96–104. doi: 10.1038/nrneurol.2016.182 - PubMed
-
- Aliaga L, Lai C, Yu J, Chub N, Shim H, Sun L, Xie C, Yang WJ, Lin X, O'Donovan MJ, Cai H. (2013). Amyotrophic lateral sclerosis-related VAPB P56S mutation differentially affects the function and survival of corticospinal and spinal motor neurons. Human Mol Genet 22, 4293–4305. doi: 10.1093/hmg/ddt279 - PMC - PubMed
-
- Alpy F, Rousseau A, Schwab Y, Legueux F, Stoll I, Wendling C, Spiegelhalter C, Kessler P, Mathelin C, Rio MC, et al.. (2013). STARD3 or STARD3NL and VAP form a novel molecular tether between late endosomes and the ER. J Cell Sci 126, 5500–5512. doi: 10.1242/jcs.139295 - PubMed
-
- Anagnostou G, Akbar MT, Paul P, Angelinetta C, Steiner TJ, de Belleroche J. (2010). Vesicle associated membrane protein B (VAPB) is decreased in ALS spinal cord. Neurobiol Aging 31, 969–985. doi: 10.1016/j.neurobiolaging.2008.07.005 - PubMed
-
- Antonny B, Bigay J, Mesmin B. (2018). The oxysterol-binding protein cycle: burning off PI(4)P to transport cholesterol. Annu Rev Biochem 87, 809–837. doi: 10.1146/annurev-biochem-061516-044924 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous